semaglutide deadline Medicare launches weight loss drug option with $50 copay : NPR FDA crackdown on off-brand Ozempic

Those who use compounded semaglutide often notice reduced appetite, which can make it harder to eat enough protein or fuel for workouts

Hope et al ., 2024, "Skeletal muscle loss and sarcopenia in obesity pharmacotherapy"

Accountability keeps momentum strong

Throughout your treatment, PlexusDx provides ongoing medication management support, side effect guidance, and access to genetic testing data that optimizes your long-term results

PlexusDx compounded optionsincluding standalone GLP-1 formulations and dual-compound GLP-Squaredare designed to support flexible, personalized dosing conversations

That's the lens I bring to the GLP-1 conversation